MarkTBergmannMDCataract Fellowship
Ophthalmology • Cincinnati, OHCataract Related, Cornea & External Disease, Refractive Surgery
Cataract Specialist/ Cornea & External Disease Specialist/ Comprehensive Ophthalmologist- Apex Eye
Dr. Bergmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6507 Harrison Avenue
Suite E
Cincinnati, OH 45247Phone+1 513-661-3566Fax+1 513-661-6469- Is this information wrong?
Clinical Expertise
- Dry eye, Cataracts, Diabetes, Laser general surgery, Clinical research, Glaucoma, No stitch, No patch, No shot cataract implant surgery. External eye disease, Diabetic eye exams, Eye research studies, Office lid lesion removal, Laser surgery-glaucoma & after cataract
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Cornea, External Diseases, and Refractive Surgery, 1987 - 1987
Cullen Eye Institute-BaylorFellowship, Cataract Fellowship, 1986 - 1986
University of ToledoResidency, Ophthalmology, 1983 - 1986
Jewish Hospital of CincinnatiInternship, Internal Medicine, 1982 - 1983
Wright State University Boonshoft School of MedicineClass of 1982
Certifications & Licensure
OH State Medical License 1983 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctor Cincinnati Magazine, 2013, 2017, 2021
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 5 citationsPhase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.John D. Sheppard, M.T. Bergmann, Barry A. Schechter, Jodi Luchs, Abayomi Ogundele, Paul M. Karpecki> ;Clinical Ophthalmology. 2021 Jan 12
- 4 citationsPooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitisEugene B McLaurin, M.T. Bergmann, Abhijit Narvekar, Adeniyi Adewale, Paul J Gomes, Gail Torkildsen> ;Clinical Ophthalmology. 2017 Jun 8
- 16 citationsEfficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model.Gail Torkildsen, Abhijit Narvekar, M.T. Bergmann> ;Clinical Ophthalmology. 2015 Sep 14
- Join now to see all
Research History
- Principal InvestigatorPrincipal Investigator for several eye drop studies related to allergy, cataract surgery, dry eyes, conjunctivitis, and glaucoma.2007 - 2017
Professional Memberships
- Fellow
Hospital Affiliations
- TriHealth Evendale HospitalCincinnati, Ohio
Mercy Health - West HospitalCincinnati, Ohio
External Links
- Cincinnati Eye Institute http://Cincinnatieye.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
